Knee injection after ACL tear may stop arthritis before it starts
NCT ID NCT03968913
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether injecting a drug called anakinra into the knee within two weeks of an ACL injury can prevent arthritis that often develops years later. Half of the 32 participants will receive the drug, and half will receive a placebo (salt water). Researchers will track pain, function, and cartilage health using MRI and urine tests for two years after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTERIOR CRUCIATE LIGAMENT INJURIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California, Los Angeles
RECRUITINGLos Angeles, California, 90095, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 3D-Printed gadget speed up knee recovery?
- Saving the ligament: a trial tests whether repairing a torn ACL beats replacing it
- Which tendon graft helps female athletes recover best after ACL surgery?
- Nerve block showdown: which technique eases ACL surgery pain best?
- Which ACL graft gets young athletes back in the game faster?
- Vibration therapy may reduce second ACL injury risk